Skip to content

ADAPTIVE BIOTECHNOLOGIES CORPORATION

ADPT

CIK 0001478320

← back to feed
Revenue (TTM)
$276.17M
+54.8% YoY Q1 Apr 2026
Net Income (TTM)
−$65.95M
+62.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.44
+63.9% YoY Q1 Apr 2026
Gross Margin
74.0%
Q1 Apr 2026
Operating Margin
-23.0%
Q1 Apr 2026
Net Margin
-23.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$142.02M
Q1 Apr 2026
Cash
$77.58M
Q1 Apr 2026
Total Debt
$130.55M
Q1 Apr 2026
Shares Outstanding
160.04M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings